Ποια είναι η τιμή για Onesource Specialty Pharma Ltd. (ONESOURCE)

Η τιμή για Onesource Specialty Pharma Ltd. (ONESOURCE) είναι $16.75

Ποια είναι η κεφαλαιοποίηση αγοράς για Onesource Specialty Pharma Ltd. (ONESOURCE)

Η κεφαλαιοποίηση αγοράς για Onesource Specialty Pharma Ltd. (ONESOURCE) είναι $1.92B

Onesource Specialty Pharma Ltd. (ONESOURCE) Διαίρεση Μετοχών

OneSource Specialty Pharma Limited is a biopharmaceutical company focused on the discovery, advancement, production, and market introduction of biological drug products, primarily offered in diverse injectable formulations. The company conducts its operations internationally, with a footprint in India, Ireland, and the United States. It delivers comprehensive contract development and manufacturing (CDMO) services for biologics, encompassing all phases from preclinical and clinical development to commercial-scale supply. Its offerings extend to integrated drug-device systems such as pre-filled syringes, various pen injectors (including dial, push, and pull-push types for both variable and fixed doses), and autoinjectors. Furthermore, OneSource Specialty Pharma manufactures sterile injectable drugs and soft gelatin capsules, and provides specialized biologics solutions tailored for microbial and mammalian cell-line biopharmaceuticals, as well as for cell, gene, and RNA therapies. Established in 2007, the company, headquartered in Bengaluru, India, was formerly known as Stelis Biopharma Limited until its rebranding in February 2024.